Evolving therapeutic goals in Crohn's disease management
Author:
Affiliation:
1. FDepartment of Hepato‐GastroenterologyUniversity Hospital of GrenobleUniversity of Grenoble AlpesGrenobleFrance
2. FDepartment of Gastroenterology and Inserm NGEREUniversity Hospital of NancyUniversity of LorraineVandoeuvre‐lès‐NancyFrance
Publisher
Wiley
Subject
Gastroenterology,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1177/2050640619887316
Reference65 articles.
1. Crohn's disease
2. Development of the Lémann Index to assess digestive tract Damage in patients With Crohn's Disease;Pariente B;Gastroenterology,2014
3. Surgery for adult Crohn's disease: what is the actual risk?
4. Treating rheumatoid arthritis to target: recommendations of an international task force
5. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Consenso de endoscopia en enfermedad inflamatoria intestinal de la Organización Panamericana de Crohn y Colitis (PANCCO) y la Sociedad Interamericana de endoscopia (SIED);Revista de Gastroenterología del Perú;2024-06-26
2. Therapeutic sequencing in inflammatory bowel disease: Determining the optimal position of vedolizumab for long‐term Crohn’s disease control using real‐world evidence;United European Gastroenterology Journal;2024-05-08
3. Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn’s Disease in US and Europe: Results from the Cross-Sectional CONFIDE Study;Digestive Diseases and Sciences;2024-05-03
4. Upadacitinib in Crohn’s disease;Expert Opinion on Pharmacotherapy;2024-03-03
5. Magnetic Resonance Enterography Assessment of Transmural Healing with Vedolizumab in Moderate to Severe Crohn’s Disease: Feasibility in the VERSIFY Phase 3 Clinical Trial;Clinical and Experimental Gastroenterology;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3